Keratin 1 modulates intestinal barrier and immune response via kallikrein kinin system in ulcerative colitis

doi:10.3748/wjg.v31.i6.102070

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 31, Issue 6

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (698)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-5) series, Tables (1-1) series.

Item

Count

PDF

HTML

406

Figures (1-5)

Tables (1-1)

Sum=599

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=61

Feb 14, 2025 (publication date) through Feb 21, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastroenterol. Feb 14, 2025; 31(6): 102070
Published online Feb 14, 2025. doi: 10.3748/wjg.v31.i6.102070

Full Size Figure Download Figure

Figure 1 Effect of different concentrations of keratin 1 antibody on Caco-2 cell proliferation and apoptosis. A and B: Keratin 1 (KRT1) antibody inhibited cellular proliferation; C: KRT1 antibody induced apoptosis. ^cP < 0.001. P value vs control group. Control refers to untreated Caco-2 cells; Treatment 1: Keratin 1 (KRT1) antibody at 1 ng/mL; Treatment 2: KRT1 antibody at 5 ng/mL; Treatment 3: KRT1 antibody at 10 ng/mL. Same for subsequent figures.

Citation: Dong XQ, Zhang YH, Luo J, Li MJ, Ma LQ, Qi YT, Miao YL. Keratin 1 modulates intestinal barrier and immune response via kallikrein kinin system in ulcerative colitis. World J Gastroenterol 2025; 31(6): 102070
URL: https://www.wjgnet.com/1007-9327/full/v31/i6/102070.htm
DOI: https://dx.doi.org/10.3748/wjg.v31.i6.102070